Skip to main content

A Taste for Life With Zarela

Zarela Martinez is a culinary legend celebrated for introducing a US audience to authentic Mexican food. A Taste for Life With Zarela is a special series that explores Zarela's inspiring approach to living with Parkinson's through her cooking and personal stories. Read more

Sign up to watch the videos

Brought to you by

INBRIJA® treats OFF periods in adults taking carbidopa/levodopa (CD/LD). INBRIJA doesn't replace CD/LD.


Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.

Please see below for additional Important Safety Information.
I love to entertain and have people around me. So cooking is a very important part of how I manage my Parkinson's.
— Zarela Martinez, chef
Living with Parkinson's and using INBRIJA

An invitation from Zarela

Read transcript

Zarela's Recipes in action

The fans have spoken

A Taste for Life With Zarela helps bring fun, fresh new flavors to people with Parkinson's and many others. Don't forget to always talk to your doctor about your diet and Parkinson's.

Sign up to watch A Taste for Life With Zarela

We'd love to learn a little bit about you. Please take a moment to answer the questions below before getting started with Zarela.

All fields are required.

Which statement describes you?

About you

By clicking sign up, you are authorizing Acorda Therapeutics, its agents, or vendors acting on behalf of Acorda to:

  • Send you information regarding A Taste for Life With Zarela
  • Send you information regarding Acorda and its products and services
  • Send you other important health, medical, or patient education information
  • Contact you to seek your participation in other surveys or programs

View our Privacy Policy

More about Zarela Martinez

Mexican-born Zarela Martinez has been a champion of Mexican cuisine and culture for American food-lovers since her restaurant, Zarela, burst on the New York scene in 1987. Her achievements as a pioneering woman chef, restaurateur, cookbook author, food television host, and product developer make her one of the first to find success on so many different platforms.

Zarela's four-decade career has grown out of her passions for cooking Mexican food and entertaining her friends. But after she was diagnosed with Parkinson's disease in 2004, both became more challenging.

From the start, Zarela decided that she wasn't going to take Parkinson's sitting down. For her, that means taking an active role in her treatment, making delicious food, and staying connected with loved ones. And when her Parkinson's symptoms return between doses of her regular carbidopa/levodopa containing medicine, she takes INBRIJA.

This site is
brought to
you by

INBRIJA is the only orally inhaled levodopa. It's for those in between times when you experience the return of Parkinson's symptoms because your carbidopa/levodopa treatment isn't working hard enough. Adding INBRIJA can help get back to the moment.

  • INBRIJA is for use as needed. Use it as prescribed when your Parkinson's symptoms start to return (1 dose per OFF period, no more than 5 doses a day).

    Do not stop taking your daily Parkinson's medicine. INBRIJA does not replace your regular carbidopa/levodopa medicine.

  • INBRIJA may start to work in as soon as 10 minutes.

  • INBRIJA is lightweight, portable, and easy to carry with you. Keep the capsules in their foil (blister) packages until just before you're ready to use them.

Store your INBRIJA at room temperature 68°F to 77°F (20°C to 25°C) in a dry place.

Selected Important Safety Information

The most common side effects of INBRIJA are cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.


INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa medicine.

Important Safety Information

Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.

Before using INBRIJA, tell your healthcare provider about your medical conditions, including:

  • asthma, chronic obstructive pulmonary disease (COPD), or any chronic lung disease
  • daytime sleepiness, sleep disorders, sleepiness/drowsiness without warning, or use of medicine that increases sleepiness, including antidepressants or antipsychotics
  • dizziness, nausea, sweating, or fainting when standing up
  • abnormal movement (dyskinesia)
  • mental health problems such as hallucinations or psychosis
  • uncontrollable urges like gambling, sexual urges, spending money, or binge eating
  • glaucoma
  • pregnancy or plans to become pregnant. It is unknown if INBRIJA will harm an unborn baby.
  • breastfeeding or plans to breastfeed. Levodopa can pass into breastmilk and it is unknown if it can harm the baby.

Tell your healthcare provider if you take:

  • MAO-B inhibitors
  • dopamine (D2) antagonists (including phenothiazines, butyrophenones, risperidone, metoclopramide)
  • isoniazid
  • iron salts or multivitamins that contain iron salts

Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can happen as late as a year after treatment is started.

Tell your healthcare provider if you experience the following side effects:

  • falling asleep during normal daily activities with or without warning. If you become drowsy, do not drive or do activities where you need to be alert. Chances of falling asleep during normal activities increases if you take medicine that cause sleepiness.
  • withdrawal-emergent hyperpyrexia and confusion (fever, stiff muscles, or changes in breathing and heartbeat) if you suddenly stop using INBRIJA or carbidopa/levodopa, or suddenly lower your dose of carbidopa/levodopa.
  • low blood pressure when standing up (that may be with dizziness, fainting, nausea, and sweating). Get up slowly after sitting/lying down.
  • hallucinations and other psychosis – INBRIJA may cause or worsen seeing/hearing/believing things that are not real; confusion, disorientation, or disorganized thinking; trouble sleeping; dreaming a lot; being overly suspicious or feeling people want to harm you; acting aggressive; and feeling agitated/restless.
  • unusual uncontrollable urges such as gambling, binge eating, shopping, and sexual urges has occurred in some people using medicine like INBRIJA.
  • uncontrolled, sudden body movements (dyskinesia) may be caused or worsened by INBRIJA. INBRIJA may need to be stopped or other Parkinson’s medicines may need to be changed.
  • bronchospasm – people with asthma, COPD, or other lung diseases may wheeze or have difficulty breathing after inhaling INBRIJA. If this occurs, stop taking INBRIJA and seek immediate medical attention.
  • increased eye pressure in patients with glaucoma. Your healthcare provider should monitor this.
  • changes in certain lab values including liver tests

The most common side effects of INBRIJA are cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.

Do not orally inhale more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) in a day.

Please see the Patient Information Leaflet.

This website is brought to you by

For more information about Acorda Therapeutics and its products, visit .

Acorda Therapeutics Inc.,
420 Saw Mill River Road,
Ardsley, NY 10502

12/20 INB9134